カテゴリー： Market Monitor Global, 世界, 医療/バイオ

皮膚線維症治療の世界市場見通し2023年-2029年

◆英語タイトル：Cutaneous Fribrosis Treatment Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8442 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：72 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Cutaneous Fribrosis Treatment Market 調査レポートは次の情報を含め、グローバルにおけるの皮膚線維症治療市場規模と予測を収録しています。・世界の皮膚線維症治療市場：売上、2018年-2023年、2024年-2029年
・世界の皮膚線維症治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の皮膚線維症治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「副腎皮質ステロイド薬」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

皮膚線維症治療のグローバル主要企業は、Pfizer、 Sanofi、 F. Hoffmann-La Roche、 Boehringer Ingelheim、 Jubilant Cadista、 Horizon Pharma USA、 Bristol-Myers Squibb Companyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、皮膚線維症治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の皮膚線維症治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の皮膚線維症治療市場：タイプ別市場シェア、2022年
・副腎皮質ステロイド薬、抗線維化治療薬、免疫治療薬、その他

世界の皮膚線維症治療市場：用途別、2018年-2023年、2024年-2029年
世界の皮膚線維症治療市場：用途別市場シェア、2022年
・病院薬局、小売薬局、その他

世界の皮膚線維症治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の皮膚線維症治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における皮膚線維症治療のグローバル売上、2018年-2023年
・主要企業における皮膚線維症治療のグローバル売上シェア、2022年
・主要企業における皮膚線維症治療のグローバル販売量、2018年-2023年
・主要企業における皮膚線維症治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Pfizer、 Sanofi、 F. Hoffmann-La Roche、 Boehringer Ingelheim、 Jubilant Cadista、 Horizon Pharma USA、 Bristol-Myers Squibb Company

*************************************************************

・調査・分析レポートの概要
皮膚線維症治療市場の定義
市場セグメント
世界の皮膚線維症治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の皮膚線維症治療市場規模
世界の皮膚線維症治療市場規模：2022年 VS 2029年
世界の皮膚線維症治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの皮膚線維症治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の皮膚線維症治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：副腎皮質ステロイド薬、抗線維化治療薬、免疫治療薬、その他
皮膚線維症治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、小売薬局、その他
皮膚線維症治療の用途別グローバル売上・予測

・地域別市場分析
地域別皮膚線維症治療市場規模 2022年と2029年
地域別皮膚線維症治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer、 Sanofi、 F. Hoffmann-La Roche、 Boehringer Ingelheim、 Jubilant Cadista、 Horizon Pharma USA、 Bristol-Myers Squibb Company
...

Cutaneous Fribrosis Treatment refers to the treatment of skin myelofibrosis by drugs such as corticosteroids, anti-fibrotic drugs, and immunotherapy drugs.
This report aims to provide a comprehensive presentation of the global market for Cutaneous Fribrosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cutaneous Fribrosis Treatment. This report contains market size and forecasts of Cutaneous Fribrosis Treatment in global, including the following market information:
Global Cutaneous Fribrosis Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Cutaneous Fribrosis Treatment Market Sales, 2018-2023, 2024-2029, (MT)
Global top five Cutaneous Fribrosis Treatment companies in 2022 (%)
The global Cutaneous Fribrosis Treatment market was valued at US$ 587.3 million in 2022 and is projected to reach US$ 872.6 million by 2029, at a CAGR of 5.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Corticosteroids Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cutaneous Fribrosis Treatment include Pfizer, Sanofi, F. Hoffmann-La Roche, Boehringer Ingelheim, Jubilant Cadista, Horizon Pharma USA and Bristol-Myers Squibb Company, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cutaneous Fribrosis Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cutaneous Fribrosis Treatment Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Cutaneous Fribrosis Treatment Market Segment Percentages, by Type, 2022 (%)
Corticosteroids
Antifibrotic Drugs
Immunotherapy Drugs
Other
Global Cutaneous Fribrosis Treatment Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Cutaneous Fribrosis Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Retail Pharmacy
Other
Global Cutaneous Fribrosis Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Cutaneous Fribrosis Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cutaneous Fribrosis Treatment revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cutaneous Fribrosis Treatment revenues share in global market, 2022 (%)
Key companies Cutaneous Fribrosis Treatment sales in global market, 2018-2023 (Estimated), (MT)
Key companies Cutaneous Fribrosis Treatment sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Sanofi
F. Hoffmann-La Roche
Boehringer Ingelheim
Jubilant Cadista
Horizon Pharma USA
Bristol-Myers Squibb Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cutaneous Fribrosis Treatment, market overview.
Chapter 2: Global Cutaneous Fribrosis Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Cutaneous Fribrosis Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cutaneous Fribrosis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cutaneous Fribrosis Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Cutaneous Fribrosis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cutaneous Fribrosis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cutaneous Fribrosis Treatment Overall Market Size
2.1 Global Cutaneous Fribrosis Treatment Market Size: 2022 VS 2029
2.2 Global Cutaneous Fribrosis Treatment Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Cutaneous Fribrosis Treatment Sales: 2018-2029
3 Company Landscape
3.1 Top Cutaneous Fribrosis Treatment Players in Global Market
3.2 Top Global Cutaneous Fribrosis Treatment Companies Ranked by Revenue
3.3 Global Cutaneous Fribrosis Treatment Revenue by Companies
3.4 Global Cutaneous Fribrosis Treatment Sales by Companies
3.5 Global Cutaneous Fribrosis Treatment Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Cutaneous Fribrosis Treatment Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Cutaneous Fribrosis Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cutaneous Fribrosis Treatment Players in Global Market
3.8.1 List of Global Tier 1 Cutaneous Fribrosis Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Cutaneous Fribrosis Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Cutaneous Fribrosis Treatment Market Size Markets, 2022 & 2029
4.1.2 Corticosteroids
4.1.3 Antifibrotic Drugs
4.1.4 Immunotherapy Drugs
4.1.5 Other
4.2 By Type – Global Cutaneous Fribrosis Treatment Revenue & Forecasts
4.2.1 By Type – Global Cutaneous Fribrosis Treatment Revenue, 2018-2023
4.2.2 By Type – Global Cutaneous Fribrosis Treatment Revenue, 2024-2029
4.2.3 By Type – Global Cutaneous Fribrosis Treatment Revenue Market Share, 2018-2029
4.3 By Type – Global Cutaneous Fribrosis Treatment Sales & Forecasts
4.3.1 By Type – Global Cutaneous Fribrosis Treatment Sales, 2018-2023
4.3.2 By Type – Global Cutaneous Fribrosis Treatment Sales, 2024-2029
4.3.3 By Type – Global Cutaneous Fribrosis Treatment Sales Market Share, 2018-2029
4.4 By Type – Global Cutaneous Fribrosis Treatment Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cutaneous Fribrosis Treatment Market Size, 2022 & 2029
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application – Global Cutaneous Fribrosis Treatment Revenue & Forecasts
5.2.1 By Application – Global Cutaneous Fribrosis Treatment Revenue, 2018-2023
5.2.2 By Application – Global Cutaneous Fribrosis Treatment Revenue, 2024-2029
5.2.3 By Application – Global Cutaneous Fribrosis Treatment Revenue Market Share, 2018-2029
5.3 By Application – Global Cutaneous Fribrosis Treatment Sales & Forecasts
5.3.1 By Application – Global Cutaneous Fribrosis Treatment Sales, 2018-2023
5.3.2 By Application – Global Cutaneous Fribrosis Treatment Sales, 2024-2029
5.3.3 By Application – Global Cutaneous Fribrosis Treatment Sales Market Share, 2018-2029
5.4 By Application – Global Cutaneous Fribrosis Treatment Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Cutaneous Fribrosis Treatment Market Size, 2022 & 2029
6.2 By Region – Global Cutaneous Fribrosis Treatment Revenue & Forecasts
6.2.1 By Region – Global Cutaneous Fribrosis Treatment Revenue, 2018-2023
6.2.2 By Region – Global Cutaneous Fribrosis Treatment Revenue, 2024-2029
6.2.3 By Region – Global Cutaneous Fribrosis Treatment Revenue Market Share, 2018-2029
6.3 By Region – Global Cutaneous Fribrosis Treatment Sales & Forecasts
6.3.1 By Region – Global Cutaneous Fribrosis Treatment Sales, 2018-2023
6.3.2 By Region – Global Cutaneous Fribrosis Treatment Sales, 2024-2029
6.3.3 By Region – Global Cutaneous Fribrosis Treatment Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Cutaneous Fribrosis Treatment Revenue, 2018-2029
6.4.2 By Country – North America Cutaneous Fribrosis Treatment Sales, 2018-2029
6.4.3 US Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.4.4 Canada Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.4.5 Mexico Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Cutaneous Fribrosis Treatment Revenue, 2018-2029
6.5.2 By Country – Europe Cutaneous Fribrosis Treatment Sales, 2018-2029
6.5.3 Germany Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.5.4 France Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.5.5 U.K. Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.5.6 Italy Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.5.7 Russia Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.5.8 Nordic Countries Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.5.9 Benelux Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Cutaneous Fribrosis Treatment Revenue, 2018-2029
6.6.2 By Region – Asia Cutaneous Fribrosis Treatment Sales, 2018-2029
6.6.3 China Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.6.4 Japan Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.6.5 South Korea Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.6.6 Southeast Asia Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.6.7 India Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Cutaneous Fribrosis Treatment Revenue, 2018-2029
6.7.2 By Country – South America Cutaneous Fribrosis Treatment Sales, 2018-2029
6.7.3 Brazil Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.7.4 Argentina Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Cutaneous Fribrosis Treatment Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Cutaneous Fribrosis Treatment Sales, 2018-2029
6.8.3 Turkey Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.8.4 Israel Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.8.5 Saudi Arabia Cutaneous Fribrosis Treatment Market Size, 2018-2029
6.8.6 UAE Cutaneous Fribrosis Treatment Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Cutaneous Fribrosis Treatment Major Product Offerings
7.1.4 Pfizer Cutaneous Fribrosis Treatment Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Cutaneous Fribrosis Treatment Major Product Offerings
7.2.4 Sanofi Cutaneous Fribrosis Treatment Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 F. Hoffmann-La Roche
7.3.1 F. Hoffmann-La Roche Company Summary
7.3.2 F. Hoffmann-La Roche Business Overview
7.3.3 F. Hoffmann-La Roche Cutaneous Fribrosis Treatment Major Product Offerings
7.3.4 F. Hoffmann-La Roche Cutaneous Fribrosis Treatment Sales and Revenue in Global (2018-2023)
7.3.5 F. Hoffmann-La Roche Key News & Latest Developments
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Company Summary
7.4.2 Boehringer Ingelheim Business Overview
7.4.3 Boehringer Ingelheim Cutaneous Fribrosis Treatment Major Product Offerings
7.4.4 Boehringer Ingelheim Cutaneous Fribrosis Treatment Sales and Revenue in Global (2018-2023)
7.4.5 Boehringer Ingelheim Key News & Latest Developments
7.5 Jubilant Cadista
7.5.1 Jubilant Cadista Company Summary
7.5.2 Jubilant Cadista Business Overview
7.5.3 Jubilant Cadista Cutaneous Fribrosis Treatment Major Product Offerings
7.5.4 Jubilant Cadista Cutaneous Fribrosis Treatment Sales and Revenue in Global (2018-2023)
7.5.5 Jubilant Cadista Key News & Latest Developments
7.6 Horizon Pharma USA
7.6.1 Horizon Pharma USA Company Summary
7.6.2 Horizon Pharma USA Business Overview
7.6.3 Horizon Pharma USA Cutaneous Fribrosis Treatment Major Product Offerings
7.6.4 Horizon Pharma USA Cutaneous Fribrosis Treatment Sales and Revenue in Global (2018-2023)
7.6.5 Horizon Pharma USA Key News & Latest Developments
7.7 Bristol-Myers Squibb Company
7.7.1 Bristol-Myers Squibb Company Company Summary
7.7.2 Bristol-Myers Squibb Company Business Overview
7.7.3 Bristol-Myers Squibb Company Cutaneous Fribrosis Treatment Major Product Offerings
7.7.4 Bristol-Myers Squibb Company Cutaneous Fribrosis Treatment Sales and Revenue in Global (2018-2023)
7.7.5 Bristol-Myers Squibb Company Key News & Latest Developments
8 Global Cutaneous Fribrosis Treatment Production Capacity, Analysis
8.1 Global Cutaneous Fribrosis Treatment Production Capacity, 2018-2029
8.2 Cutaneous Fribrosis Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Cutaneous Fribrosis Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cutaneous Fribrosis Treatment Supply Chain Analysis
10.1 Cutaneous Fribrosis Treatment Industry Value Chain
10.2 Cutaneous Fribrosis Treatment Upstream Market
10.3 Cutaneous Fribrosis Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cutaneous Fribrosis Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Cutaneous Fribrosis Treatment in Global Market
Table 2. Top Cutaneous Fribrosis Treatment Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Cutaneous Fribrosis Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Cutaneous Fribrosis Treatment Revenue Share by Companies, 2018-2023
Table 5. Global Cutaneous Fribrosis Treatment Sales by Companies, (MT), 2018-2023
Table 6. Global Cutaneous Fribrosis Treatment Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Cutaneous Fribrosis Treatment Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Cutaneous Fribrosis Treatment Product Type
Table 9. List of Global Tier 1 Cutaneous Fribrosis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cutaneous Fribrosis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Cutaneous Fribrosis Treatment Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Cutaneous Fribrosis Treatment Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Cutaneous Fribrosis Treatment Sales (MT), 2018-2023
Table 15. By Type - Global Cutaneous Fribrosis Treatment Sales (MT), 2024-2029
Table 16. By Application – Global Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Cutaneous Fribrosis Treatment Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Cutaneous Fribrosis Treatment Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Cutaneous Fribrosis Treatment Sales (MT), 2018-2023
Table 20. By Application - Global Cutaneous Fribrosis Treatment Sales (MT), 2024-2029
Table 21. By Region – Global Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Cutaneous Fribrosis Treatment Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Cutaneous Fribrosis Treatment Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Cutaneous Fribrosis Treatment Sales (MT), 2018-2023
Table 25. By Region - Global Cutaneous Fribrosis Treatment Sales (MT), 2024-2029
Table 26. By Country - North America Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Cutaneous Fribrosis Treatment Sales, (MT), 2018-2023
Table 29. By Country - North America Cutaneous Fribrosis Treatment Sales, (MT), 2024-2029
Table 30. By Country - Europe Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Cutaneous Fribrosis Treatment Sales, (MT), 2018-2023
Table 33. By Country - Europe Cutaneous Fribrosis Treatment Sales, (MT), 2024-2029
Table 34. By Region - Asia Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Cutaneous Fribrosis Treatment Sales, (MT), 2018-2023
Table 37. By Region - Asia Cutaneous Fribrosis Treatment Sales, (MT), 2024-2029
Table 38. By Country - South America Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Cutaneous Fribrosis Treatment Sales, (MT), 2018-2023
Table 41. By Country - South America Cutaneous Fribrosis Treatment Sales, (MT), 2024-2029
Table 42. By Country - Middle East & Africa Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Cutaneous Fribrosis Treatment Sales, (MT), 2018-2023
Table 45. By Country - Middle East & Africa Cutaneous Fribrosis Treatment Sales, (MT), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Cutaneous Fribrosis Treatment Product Offerings
Table 48. Pfizer Cutaneous Fribrosis Treatment Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Cutaneous Fribrosis Treatment Product Offerings
Table 52. Sanofi Cutaneous Fribrosis Treatment Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. Sanofi Key News & Latest Developments
Table 54. F. Hoffmann-La Roche Company Summary
Table 55. F. Hoffmann-La Roche Cutaneous Fribrosis Treatment Product Offerings
Table 56. F. Hoffmann-La Roche Cutaneous Fribrosis Treatment Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. F. Hoffmann-La Roche Key News & Latest Developments
Table 58. Boehringer Ingelheim Company Summary
Table 59. Boehringer Ingelheim Cutaneous Fribrosis Treatment Product Offerings
Table 60. Boehringer Ingelheim Cutaneous Fribrosis Treatment Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. Boehringer Ingelheim Key News & Latest Developments
Table 62. Jubilant Cadista Company Summary
Table 63. Jubilant Cadista Cutaneous Fribrosis Treatment Product Offerings
Table 64. Jubilant Cadista Cutaneous Fribrosis Treatment Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. Jubilant Cadista Key News & Latest Developments
Table 66. Horizon Pharma USA Company Summary
Table 67. Horizon Pharma USA Cutaneous Fribrosis Treatment Product Offerings
Table 68. Horizon Pharma USA Cutaneous Fribrosis Treatment Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 69. Horizon Pharma USA Key News & Latest Developments
Table 70. Bristol-Myers Squibb Company Company Summary
Table 71. Bristol-Myers Squibb Company Cutaneous Fribrosis Treatment Product Offerings
Table 72. Bristol-Myers Squibb Company Cutaneous Fribrosis Treatment Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 73. Bristol-Myers Squibb Company Key News & Latest Developments
Table 74. Cutaneous Fribrosis Treatment Production Capacity (MT) of Key Manufacturers in Global Market, 2021-2023 (MT)
Table 75. Global Cutaneous Fribrosis Treatment Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Cutaneous Fribrosis Treatment Production by Region, 2018-2023 (MT)
Table 77. Global Cutaneous Fribrosis Treatment Production by Region, 2024-2029 (MT)
Table 78. Cutaneous Fribrosis Treatment Market Opportunities & Trends in Global Market
Table 79. Cutaneous Fribrosis Treatment Market Drivers in Global Market
Table 80. Cutaneous Fribrosis Treatment Market Restraints in Global Market
Table 81. Cutaneous Fribrosis Treatment Raw Materials
Table 82. Cutaneous Fribrosis Treatment Raw Materials Suppliers in Global Market
Table 83. Typical Cutaneous Fribrosis Treatment Downstream
Table 84. Cutaneous Fribrosis Treatment Downstream Clients in Global Market
Table 85. Cutaneous Fribrosis Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Cutaneous Fribrosis Treatment Segment by Type in 2022
Figure 2. Cutaneous Fribrosis Treatment Segment by Application in 2022
Figure 3. Global Cutaneous Fribrosis Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cutaneous Fribrosis Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cutaneous Fribrosis Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. Cutaneous Fribrosis Treatment Sales in Global Market: 2018-2029 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Cutaneous Fribrosis Treatment Revenue in 2022
Figure 9. By Type - Global Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Cutaneous Fribrosis Treatment Revenue Market Share, 2018-2029
Figure 11. By Type - Global Cutaneous Fribrosis Treatment Sales Market Share, 2018-2029
Figure 12. By Type - Global Cutaneous Fribrosis Treatment Price (USD/MT), 2018-2029
Figure 13. By Application - Global Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Cutaneous Fribrosis Treatment Revenue Market Share, 2018-2029
Figure 15. By Application - Global Cutaneous Fribrosis Treatment Sales Market Share, 2018-2029
Figure 16. By Application - Global Cutaneous Fribrosis Treatment Price (USD/MT), 2018-2029
Figure 17. By Region - Global Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Cutaneous Fribrosis Treatment Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Cutaneous Fribrosis Treatment Revenue Market Share, 2018-2029
Figure 20. By Region - Global Cutaneous Fribrosis Treatment Sales Market Share, 2018-2029
Figure 21. By Country - North America Cutaneous Fribrosis Treatment Revenue Market Share, 2018-2029
Figure 22. By Country - North America Cutaneous Fribrosis Treatment Sales Market Share, 2018-2029
Figure 23. US Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Cutaneous Fribrosis Treatment Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Cutaneous Fribrosis Treatment Sales Market Share, 2018-2029
Figure 28. Germany Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. France Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Cutaneous Fribrosis Treatment Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Cutaneous Fribrosis Treatment Sales Market Share, 2018-2029
Figure 37. China Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. India Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Cutaneous Fribrosis Treatment Revenue Market Share, 2018-2029
Figure 43. By Country - South America Cutaneous Fribrosis Treatment Sales Market Share, 2018-2029
Figure 44. Brazil Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Cutaneous Fribrosis Treatment Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Cutaneous Fribrosis Treatment Sales Market Share, 2018-2029
Figure 48. Turkey Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Cutaneous Fribrosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 52. Global Cutaneous Fribrosis Treatment Production Capacity (MT), 2018-2029
Figure 53. The Percentage of Production Cutaneous Fribrosis Treatment by Region, 2022 VS 2029
Figure 54. Cutaneous Fribrosis Treatment Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 皮膚線維症治療の世界市場見通し2023年-2029年(Cutaneous Fribrosis Treatment Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

皮膚線維症治療の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp